Answers are grounded in this paper and cite their sources.
A 55-year-old male with chronic lymphocytic leukemia developed a skin eruption after receiving oral cyclophosphamide. Subsequent rechallenge with parenteral cyclophosphamide led to recurrence of the skin lesions, which on biopsy were shown to be vasculitic in nature.
No takes yet. Share an insight, caveat, or question.
Green et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: